P946: Real life management of patients with active perianal fistulizing Crohn’s disease (ALERT-CD study)ECCO'24Year: 2024
Authors: Bak, M.(1)*;Stassen, L.(2);Buskens, C.(3);Pronk, A.(3);van der Bilt, J.(4);Gecse, K.(5);de Boer, N.(5);Witjes, C.(6);Fitzpatrick, C.(7);Nissen, L.(8);Verdaasdonk, E.(9);Pierik, M.(10);Breukink, S.(2);Gillissen, L.(11);Bloemen, J.(12);West, R.(13);Kortekaas, R.(14);Mares, W.(15);de Jong, G.(16);Jansen, S.(17);Bloemendaal, B.(18);Sikkema, M.(19);Zimmerman, D.(20);Peeters, K.(21);van der Meulen- de Jong, A.(22);van Schaik, F.(23);Richir, M.(24);van Dongen , K.(25);Duijvestein, M.(26);Hoogenboom, F.(27);Visschedijk, M.(28);de Vries, A.(1);van Ruler, O.(6);
(1)Erasmus University Medical Center Rotterdam, Department of Gastroenterology and Hepatology, Rotterdam, The Netherlands;(2)Maastricht University Medical Center, Department of Surgery, Maastricht, The Netherlands;(3)Amsterdam University Medical Center, Department of Surgery, Amsterdam, The Netherlands;(4)Flevoziekenhuis, Department of Surgery, Almere, The Netherlands;(5)Amsterdam University Medical Center, Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands;(6)IJsselland Hospital, Department of Surgery, Capelle aan den IJssel, The Netherlands;(7)IJsselland Hospital, Department of Gastroenterology and Hepatology, Capelle aan den IJssel, The Netherlands;(8)Jeroen Bosch Hospital, Department of Gastroenterology and Hepatology, @E@s Hertogenbosch, The Netherlands;(9)Jeroen Bosch Hospital, Department of Surgery, @E@s Hertogenbosch, The Netherlands;(10)Maastricht University Medical Center, Department of Gastroenterology and Hepatology, Maastricht, The Netherlands;(11)Catharina Hospital, Department of Gastroenterology and Hepatology, Eindhoven, The Netherlands;(12)Catharina Hospital, Department of Surgery, Eindhoven, The Netherlands;(13)Franciscus Gasthuis & Vlietland, Department of Gastroenterology and Hepatology, Rotterdam, The Netherlands;(14)Franciscus Gasthuis & Vlietland, Department of Surgery, Rotterdam, The Netherlands;(15)Gelderse Vallei, Department of Gastroenterology and Hepatology, Ede, The Netherlands;(16)Gelderse Vallei, Department of Surgery, Ede, The Netherlands;(17)Reinier de Graaf Groep, Department of Gastroenterology and Hepatology, Delft, The Netherlands;(18)Reinier de Graaf Groep, Department of Surgery, Delft, The Netherlands;(19)Elisabeth TweeSteden Hospital, Department of Gastroenterology and Hepatology, Tilburg, The Netherlands;(20)Elisabeth TweeSteden Hospital, Department of Surgery, Tilburg, The Netherlands;(21)Leiden University Medical Center, Department of Surgery, Leiden, The Netherlands;(22)Leiden University Medical Center, Department of Gastroenterology and Hepatology, Leiden, The Netherlands;(23)University Medical Center Utrecht, Department of Gastroenterology and Hepatology, Utrecht, The Netherlands;(24)University Medical Center Utrecht, Department of Surgery, Utrecht, The Netherlands;(25)Maasziekenhuis Pantein, Department of Surgery, Boxmeer, The Netherlands;(26)RadboudUMC, Department of Gastroenterology and Hepatology, Nijmegen, The Netherlands;(27)University Medical Center Groningen, Department of Surgery, Groningen, The Netherlands;(28)University Medical Center Groningen, Department of Gastroenterology and Hepatology, Groningen, The Netherlands;on behalf of the ALERT-CD study group on behalf of the Dutch Initiative on Crohn and Colitis – Surgery (ICC-S) and Dutch Initiative on Crohn and Colitis (ICC)
P947: medical cannabis increases appetite but not body weight in patients with inflammatory bowel diseasesECCO'24Year: 2024
Authors: Fliss Isakov, N.(1);Seidenberg, C.(2);Meiri, D.(3);Yackobovitch-Gavan, M.(4);Maharshak, N.(1);Hirsch, A.(5)*;
(1)Tel Aviv Medical Center, Department of Gastroenterology and Liver Diseases, Tel Aviv, Israel;(2)Hebrew University of Jerusalem, School of Pharmacy, Jerusalem, Israel;(3)Technion- Israel Institute of Technology, The Laboratory of Cancer Biology and Natural Drug Discovery- Faculty of Biology, Haifa, Israel;(4)Tel Aviv University, Dept. of Epidemiology and Preventive Medicine- School of Public Health- Faculty of Medicine, Tel Aviv, Israel;(5)Tel Aviv Medical Center, Department of Gastroenterology, Tel Aviv, Israel;
P948: Hand Grip Strength is a useful objective measure associated with fatigue and impaired quality of life in patients with inflammatory bowel diseaseECCO'24Year: 2024
Authors: Stack, R.(1,2)*;Ní Chonnacháin, C.(3,4);Doherty, J.(1,2);O@E@Moran, N.(1,2);Girod, P.(1);Noronha, N.(3,4);Gibney, E.R.(3,4);Doherty, G.A.(1,2);
(1)St. Vincent@E@s University Hospital, Gastroenterology, Dublin, Ireland;(2)University College Dublin, School of Medicine, Dublin, Ireland;(3)University College Dublin, Institute of Food and Health, Dublin, Ireland;(4)University College Dublin, Food for Health Ireland, Dublin, Ireland;
P949: Effectiveness and safety of rectal tacrolimus in patients with ulcerative colitis. TACRO-TOPIC study. A multicenter study from the young group of GETECCU.ECCO'24Year: 2024
Authors: Fuentes-Valenzuela, E.(1)*;Bastón-Rey, I.(2);García-Alonso, F.J.(1);Leo Carnerero , E.(3); Garcia de la Filia, I.(4);Pedraza Pérez, A.(5);Sáiz Chumillas, R.M.(6);Pascual Oliver, A.(7);Muñoz Villafranca, C.(8);Moreno, V.(9);Suárez Ferrer, C.(10);Molina Arriero, G.(11);Ferreiro-Iglesias, R.(12);Vega Villaamil, P.(13);Gardeazábal Mateos, D.(14);Segarra-Ortega, J.X.(15);Garrido Marín, A.(16);Doallo, A.I.(17);Elosua, A.(18);Alonso-Galán, H.(19);Brunet- Mas, E.(20);Jimenez García, N.(21);López Romero-Salazar , F.(22);Velayos, B.(23);Carballo-Folgoso, L.(24);Pérez Santamaría, C.(25);Mata Román, L.(26);Núñez Ortiz, A.(3);Barrio, J.(1);Barreiro-de Acosta, M.(2);Gutiérrez-Casbas, A.(9);
(1)Hospital Universitario Rio Hortega, Gastroenterology Department., Valladolid, Spain;(2)Hospital Clínico de Santiago- Fundación Instituto de Investigación Sanitaria de Santiago de Compostela FIDIS, Gastroenterology Department., Santiago de Compostela, Spain;(3)Hospital Universitario Virgen del Rocío, Gastroenterology Department., Sevilla, Spain;(4)Hospital Universitario Ramón y Cajal, Gastroenterology Department., Madrid, Spain;(5)Hospital Universitario de Álava, Gastroenterology Department, Vitoria, Spain;(6)Hospital Universitario de Burgos, Gastroenterology Department, Burgos, Spain;(7)Hospital Universitario Miguel Servet, Gastroenterology Department., Zaragoza, Spain;(8)Hospital Universitario de Basurto, Gastroenterology Department., Bilbao, Spain;(9)Hospital General Universitario de Alicante- ISABIAL. CIBERehd, Gastroenterology Department., Alicante, Spain;(10)Hospital Universitario La Paz, Gastroenterology Department., Madrid, Spain;(11)Complejo Hospitalario Universitario de Ferrol, Gastroenterology Department., Ferrol, Spain;(12)Hospital Clínico de Santiago- Fundación Instituto de Investigación Sanitaria de Santiago de Compostela FIDIS, Gastroenterology Department, Santiago de Compostela, Spain;(13)Complexo Hospitalario Universitario de Ourense, Gastroenterology Department., Ourense, Spain;(14)Hospital Universitario de Galdakao, Galdakao, Galdakao, Spain;(15)Hospital Universitario de Salamanca, Gastroenterology Department., Salamanca, Spain;(16)Hospital Universitario La Fe, Gastroenterology Department., Valencia, Spain;(17)Complejo Hospitalario Universitario de Vigo, Gastroenterology Department., Vigo, Spain;(18)Hospital de García Orcoyen, Gastroenterology Department., Estella, Spain;(19)Hospital Universitario de Donostia- Instituto Biogipuzkoa, Gastroenterology Department., Donostia, Spain;(20)Hospital Parc Tauli, Gastroenterology Department., Sabadell, Spain;(21)Hospital Universitario de Elche, Gastroenterology Department., Elche, Spain;(22)Hospital Universitario 12 de Octubre, Gastroenterology Department., Madrid, Spain;(23)Hospital Clínico Universitario de Valladolid, Gastroenterology Department., Valladolid, Spain;(24)Hospital Universitario Central de Asturias, Gastroenterology Department., Oviedo, Spain;(25)Hospital Universitario de Móstoles, Gastroenterology Department., Mósteles, Spain;(26)Hospital de Medina del Campo, Gastroenterology Department., Medina del Campo, Spain;
P951: Efficacy and safety of tofacitinib for the treatment of moderate- severe ulcerative colitis in biologic naïve patientsECCO'24Year: 2024
Authors: Liatsos, C.(1)*;Michalopoulos, G.(2);Tzouvala, M.(3);Giouleme, O.(4);Kozompoli, D.(5);Mousourakis, K.(5);Kyriakos, N.(1);Giakoumis, M.(1);Striki, A.(2);Karoumpalis, I.(2);Bellou, G.(3);Zacharopoulou, E.(3);Katsoula, A.(4);Kalogirou, M.(4);Viazis, N.(5);
(1)401 General Military Hospital of Athens, Gastroenterology, Athens, Greece;(2)G. Genimatas- General Hospital, Gastroenterology, Athens, Greece;(3)General Hospital Nikaias-Piraeus, Gastroenterology, Athens, Greece;(4)General Hospital “Hippokratio, 2nd Propaedeutic Department of Internal Medicine, Thessaloniki, Greece;(5)Evangelismos General Hospital, Gastroenterology, Athens, Greece;
P952: Why do patients with Inflammatory Bowel Disease Take Part in Pharmaceutical Clinical Trials? A qualitative study of Clinical Trial ParticipantsECCO'24Year: 2024
Authors: Solitano, V.(1)*;Prins, H.(1);Archer, M.(1);Guizzetti, L.(2);Jairath, V.(1,3);
(1)Western University, Division of Gastroenterology- Department of Medicine, London- Ontario, Canada;(2)Independent Researcher, Independent Researcher, London- Ontario, Canada;(3)Western University, Department of Epidemiology and Biostatistics, London- Ontario, Canada;
P953: Establishment and Internal Validation of a Clinical Risk Score to Predict the Efficacy of Adalimumab in Crohn@E@s DiseaseECCO'24Year: 2024
Authors: Wang, F.(1);Liang, J.(2)*;
(1)State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers and National Clinical Research Center for Digestive Diseases- Xijing Hospital of Digestive Diseases- Fourth Military Medical University, Digestive Disease, Xi@E@an, China;(2)Xijing hospital, State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers and National Clinical Research Center for Digestive Diseases- Xijing Hospital of Digestive Diseases- Fourth Military Medical University, Xi’an, China;
DOP01: The effect of vedolizumab on CD8 T cell repertoire homogeneity and blood-gut trafficking in patients with inflammatory bowel diseaseECCO’23 CopenhagenYear: 2023
Authors: Williams, K.(1);Shows, D.(2);Kongala, R.(2);Clarke, A.(3);Lord, J.(2)*;
(1)University of Colorado, Medicine, Denver, United States;(2)Benaroya Research Institute, Translational Research, Seattle, United States;(3)Seattle Genetics, Early Stage Ind to Medicine Research, Seattle, United States;
DOP02: Single cell RNA sequencing of Ulcerative Colitis and Crohn's Disease tissue samples informs the selection of Triggering Receptors Expressed on Myeloid Cells 1 (TREM1) as a target for the treatment of Inflammatory Bowel DiseasesECCO’23 CopenhagenYear: 2023
Authors: Grant, S.(1)*;Johnson, K.(1);Thomas, T.(2);Honig, G.(1);Bielecki, P.(1);Dendrou, C.(3);Guo, S.(1);Kulicke, R.(1);Li, P.(1);L'Italien, L.(1);Spies, N.(1);Stransky, N.(1);Uhlig, H.(4);Varma, M.(1);Travis, S.(5);Buckley, C.(2);Magram, J.(1);
(1)Celsius Therapeutics, Research and Development, Cambridge MA, United States;(2)Kennedy Institute of Rheumatology, University of Oxford, Oxford, United Kingdom;(3)Wellcome Centre for Human Genetics, University of Oxford, Oxford, United Kingdom;(4)Translational Gastroenterology Unit and Department of Pediatrics, University of Oxford, Oxford, United Kingdom;(5)Kennedy Institute and Translational Gastroenterology Unit, University of Oxford, Oxford, United Kingdom;
DOP03: Unfermented β-fructan fibres can induce gut inflammation and tumorigenesis in select Inflammatory Bowel Disease patients mediated by gut microbiotaECCO’23 CopenhagenYear: 2023
Authors: Voisin, A.(1);Mahmood, R.(2);Jeanson, T.L.(2);Bernstein, C.(2);Armstrong, H.(2)*;
(1)University of Manitoba, Medical Microbiology and Infectious Diseases, Winnipeg, Canada;(2)University of Manitoba, Internal Medicine, Winnipeg, Canada;IBD Clinical and Research Centre
DOP04: Single cell RNA sequencing reveals a potential role for IFNγ in priming circulating monocytes for intestinal inflammatory function in Crohn's Disease.ECCO’23 CopenhagenYear: 2023
Authors: Hornsby, E.(1)*;Gadhok, R.(1);Yadon, A.N.(2);Lindsay, J.O.(1);Stagg, A.J.(1);
(1)Queen Mary University of London, Blizard Institute, London, United Kingdom;(2)Gilead Sciences- Inc, 199 East Blaine Street, Seattle, United States;
DOP05: Single-cell RNAseq temporal analysis of ulcerative colitis patients undergoing tofacitinib treatment reveals a shift in myeloid cells towards pro-inflammatory phenotypes in refractory patientsECCO’23 CopenhagenYear: 2023
Authors: Melon, E.(1)*;Veny, M.(1);Corraliza, A.M.(1);Garrido-Trigo, A.(1);Esteller, M.(1);Rodrigo, M.(2);Verstockt, B.(3);Vermeire, S.(4);Masamunt, M.C.(1);Giner, Á.(1);Ordás, I.(1);Fernández-Clotet, A.(1);Ricart, E.(1);Panés, J.(1);Salas, A.(1);
(1)Institut d'Investigacions Biomèdiques August Pi i Sunyer IDIBAPS, Hospital Clinic of Barcelona - Inflammatory Bowel Disease Unit, Barcelona, Spain;(2)Institut d'Investigacions Biomèdiques August Pi i Sunyer IDIBAPS, Department of Pathology- Hospital Clínic, Barcelona, Spain;(3)KU Leuven, Department of Chronic Diseases- Metabolism and Ageing- Translational Research Center- Department of Gastroenterology and Hepatology- University Hospitals Leuven for Gastrointestinal Disorders TARGID, Leuven, Belgium;(4)KU Leuven, Department of Chronic Diseases- Metabolism and Ageing- Translational Research Center for Gastrointestinal Disorders TARGID- Department of Gastroenterology and Hepatology- University Hospitals Leuven, Leuven, Belgium;
DOP06: Deep characterization of IL-23 pathway in different gut segments and associated plasma biomarkers in inflammatory bowel diseaseECCO’23 CopenhagenYear: 2023
Authors: Cairns, J.(1)*;Monkley, S.(2);Tian, S.(3);Angermann, B.(2);Liu, Z.(4);Öberg, L.(5);Muthas, D.(2);Cabrera, C.(6);Rapsomaniki, E.(7);Fernández Llaneza, D.(7);Olsson, M.(8);Paraskos, J.(9);Ellison, G.(10);Khan, E.(11);Duncan, E.A.(12);Neisen, J.(13);Gehrmann, U.(5);Chamberlain, C.(3);
(1)AstraZeneca, Translational Science and Experimental Medicine- Research and Early Development- Respiratory and Immunology R&I- BioPharmaceuticals R&D, Mölndal, Sweden;(2)AstraZeneca, Translational Science & Experimental Medicine- Research and Early Development- Respiratory and Immunology R&I- BioPharmaceuticals R&D, Mölndal, Sweden;(3)AstraZeneca, Translational Science & Experimental Medicine- Research and Early Development- Respiratory and Immunology R&I- BioPharmaceuticals R&D, Granta Park, United Kingdom;(4)AstraZeneca, Translational Science & Experimental Medicine- Research and Early Development- Respiratory and Immunology R&I- BioPharmaceuticals R&D, Gaithersburg, United States;(5)AstraZeneca, Translational Science & Experimental Medicine- Research and Early Development- Respiratory and Immunology R&I- BioPharmaceuticals R&D-, Mölndal, Sweden;(6)AstraZeneca, Evidence- Real World Science & Analytics, Mölndal, Sweden;(7)AstraZeneca, Evidence- Real World Science & Analytics, Cambridge, United Kingdom;(8)AstraZeneca, BioPharma Early Biometrics and Statistical Innovation, Mölndal, Sweden;(9)AstraZeneca, Precision Medicine & Biosamples- Oncology R&D, Cambridge, United Kingdom;(10)AstraZeneca, Precision Medicine & Biosamples- Oncology R&D, Macclesfield, United Kingdom;(11)AstraZeneca, Clinical Development- Research and Late Development- Respiratory and Immunology R&I- BioPharmaceuticals R&D, Cambridge, United Kingdom;(12)AstraZeneca, Clinical Development- Research and Late Development- Respiratory and Immunology R&I- BioPharmaceuticals R&D, Durham, United States;(13)AstraZeneca, Translational Science & Experimental Medicine- Research and Early Development- Respiratory and Immunology R&I- BioPharmaceuticals R&D-, Granta Park, United Kingdom;
DOP08: Cellular and molecular interaction of MAIT in mucosal tissue and their role in inflammatory bowel diseaseECCO’23 CopenhagenYear: 2023
Authors: Bosáková, V.(1,2)*;Frič, J.(1,3);
(1)St. Anne's University Hospital Brno, International Clinical Research Center, Brno, Czech Republic;(2)Masaryk University- Faculty of Medicine, Department of Biology, Brno, Czech Republic;(3)Institute of Hematology and Blood Transfusion, Department of Modern Immunotherapy, Prague, Czech Republic;
DOP09: Eosinophils exert a pro-inflammatory role in a chronic DSS colitis model without an impact on fibrosisECCO’23 CopenhagenYear: 2023
Authors: Jacobs, I.(1)*;Deleu, S.(2);Cremer, J.(1,2);De Hertogh, G.(3);Vermeire, S.(2,4);Breynaert, C.(1,5);Vanuytsel, T.(2,4);Verstockt, B.(2,4);
(1)KU Leuven, Department of Microbiology- Immunology and Transplantation, Leuven, Belgium;(2)KU Leuven, Department of Chronic Diseases and Metabolism, Leuven, Belgium;(3)KU Leuven, Department of Imaging and Pathology, Leuven, Belgium;(4)University Hospitals Leuven, Department of Gastroenterology and Hepatology, Leuven, Belgium;(5)University Hospitals Leuven, Department of General Internal Medicine, Leuven, Belgium;
DOP10: Early intestinal resection in Crohn's Disease is not associated with severe long-term disease courseECCO’23 CopenhagenYear: 2023
Authors: Grellier, N.(1,2)*;Kirchgesner, J.(1);Uzzan, M.(3,4);Mclellan, P.(1);Stefanescu, C.(3,5);Lefèvre, J.H.(6);Panis, Y.(5,7);Sokol, H.(1);Beaugerie, L.(1);Treton, X.(3,5);Seksik, P.(1);
(1)Saint-Antoine Hospital - Assistance Publique Hôpitaux de Paris, Department of Gastroenterology, Paris, France;(2)Centre Hospitalier Universitaire de Poitiers, Department of Hepato-gastroenterology, Poitiers, France;(3)Beaujon Hospital - Assistance Publique Hôpitaux de Paris, Department of Gastroenterology - IBD unit, Clichy, France;(4)Henri Mondor Hospital - Assistance Publique Hôpitaux de Paris, Department of Gastroenterology, Créteil, France;(5)CMC Ambroise Pare - Hartmann, Paris IBD Center, Neuilly, France;(6)Saint-Antoine Hospital - Assistance Publique Hôpitaux de Paris, Department of Digestive Surgery, Paris, France;(7)Beaujon Hospital - Assistance Publique Hôpitaux de Paris, Department of Colorectal Surgery, Clichy, France;ERIC
DOP11: A novel diagnostic serum protein signature for paediatric Inflammatory Bowel Disease: A discovery and validation study in two independent inception cohortsECCO’23 CopenhagenYear: 2023
Authors: Bache-Wiig Mathisen, C.(1,2)*;Nyström, N.(3);Bazov, I.(4);Andersen, S.(5);Olbjørn, C.(6);Perminow, G.(7);Kristensen, V.A.(1,8);Opheim, R.(1,9);Ricanek, P.(10,11);D`Amato, M.(12,13,14);Carlson, M.(15);Hedin, C.R.(16,17);Keita, Å.V.(18);Kruse, R.(19);Lindqvist, C.M.(20);Magnusson, M.K.(21);Salihovic, S.(22,23);Söderholm, J.D.(18);Öhman, L.(21);Repsilber, D.(4);Høivik, M.L.(1,2);Halfvarson, J.(24);
(1)Oslo University Hospital, Department of Gastroenterology, Oslo, Norway;(2)University of Oslo, Institute of Clinical Medicine, Oslo, Norway;(3)Uppsala Univeristy Hospital, Department of Women's and Children's health, Uppsala, Sweden;(4)Örebro University, School of Medical Sciences, Örebro, Sweden;(5)Vestfold Hospital trust, Department of Pediatrics, Tønsberg, Norway;(6)Akershus University Hospital, Department of Pediatric and Adolescent Medicine, Lørenskog, Norway;(7)Oslo University Hospital, Department of Pediatric Medicine, Oslo, Norway;(8)Lovisenberg Diaconal Hospital, Unger-Vetlesen Institute, Oslo, Norway;(9)University of Oslo, Faculty of Medicine, Oslo, Norway;(10)Lovisenberg Diaconal Hospital, Department of Gastroenterology, Oslo, Norway;(11)Akershus University Hospital, Department of Gastroenterology, Lørenskog, Norway;(12)Karolinska Institutet, Clinical Epidemiology Division- Department of Medicine Solna, Stockholm, Sweden;(13)IKERBASQUE, Basque Foundation for Science, Bilbao, Spain;(14)CIC bioGUNE - BRTA, Gastrointestinal Genetics Lab, Derio, Spain;(15)Uppsala University, Department of Medical Sciences, Uppsala, Sweden;(16)Karolinska Institute, Department of Medicine Solna, Stockholm, Sweden;(17)Karolinska University Hospital, Gastroenterology unit- Department of Gastroenterology- Dermatovenereology and Rheumatology, Oslo, Sweden;(18)Linköping University, Department of Biomedical and Clinical Sciences, Linköping, Sweden;(19)Örebro University, Department of Clinical Research Laboratory- Faculty of Medicine and Health, Örebro, Sweden;(20)Örebro University, School of Medical Sciences- Faculty of Medicine and Health, Örebro, Sweden;(21)University of Gothenburg, Department of Microbiology and Immunology- Institute of Biomedicine- Sahlgrenska Academy, Gothenburg, Sweden;(22)Örebro University, School of Medical Sciences - Inflammatory Response and Infection Susceptibility Centre, Örebro, Sweden;(23)Örebro University, School of Science and Technology- MTM Research Centre, Örebro, Sweden;(24)Örebro University, Department of Gastroenterology- Faculty of Medicine and Health, Örebro, Sweden;
DOP12: Validation of radiomics features on MR enterography characterizing inflammation and fibrosis in stricturing Crohn's diseaseECCO’23 CopenhagenYear: 2023
Authors: Sleiman, J.(1)*;Chirra, P.(2);Gandhi, N.(3);Gordon, I.O.(4);Viswanath, S.(2);Rieder, F.(5,6);
(1)University of Pittsburgh Medical Center, Department of Gastroenterology- Hepatology & Nutrition, Pittsburgh, United States;(2)Case Western Reserve University, Department of Biomedical Engineering, Cleveland, United States;(3)Cleveland Clinic Foundation, Imaging Institute, Cleveland, United States;(4)Cleveland Clinic Foundation, Department of Pathology- Robert J Tomsich Pathology and Laboratory Medicine Institute, Cleveland, United States;(5)Cleveland Clinic Foundation, Department of Gastroenterology- Hepatology & Nutrition- Digestive Diseases and Surgery Institute, Cleveland, United States;(6)Lerner Research Institute, Department of Inflammation and Immunity, Cleveland, United States;Stenosis Therapy and Anti-Fibrotic Research (STAR) Consortium
